Live from the NIH registry
Studies recruiting near Mauldin right now
Top 25 of 382 recruiting studies, sorted by proximity — each links to its official registry page
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
AnMed Health Pulmonary and Sleep Medicine — Anderson, South Carolina (27.6 mi)
· Sponsor: Synairgen Research Ltd.
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
Prisma Health Cancer Institute — Greenville, South Carolina (7.1 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 33 — Greenville, South Carolina (7.1 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
Bon Secours St. Francis Cancer Center — Greenville, South Carolina (7.1 mi)
· Sponsor: Sellas Life Sciences Group
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Greenville, South Carolina (7.1 mi)
· Sponsor: AstraZeneca
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 600 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (7.1 mi)
· Sponsor: NRG Oncology
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (7.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
Phase 1
Interventional 80 participants sought
Greenville Hospital System University Medical Center (ITOR) — Greenville, South Carolina (7.1 mi)
· Sponsor: FBD Biologics Limited
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (7.1 mi)
· Sponsor: National Cancer Institute (NCI)
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Advanced Cancer, Metastatic Cancer
N/A
Interventional 1,000 participants sought
Gibbs Cancer Center — Spartanburg, South Carolina (24.0 mi)
· Sponsor: Alliance Foundation Trials, LLC.
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Saint Francis Hospital — Greenville, South Carolina (7.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
GORE® ENFORM Biomaterial Product Study
Hernia, Ventral, Hernia, Hiatal
N/A
Interventional 245 participants sought
Prisma Health - Upstate — Greenville, South Carolina (7.1 mi)
· Sponsor: W.L.Gore & Associates
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Solid Tumor, Advanced Solid Tumor
Phase 1, Phase 2
Interventional 61 participants sought
Greenville Hospital System University Medical Center (ITOR) — Greenville, South Carolina (7.1 mi)
· Sponsor: Impact Therapeutics, Inc.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (7.1 mi)
· Sponsor: National Cancer Institute (NCI)
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
Breast Cancer, Gynecologic Cancers
N/A
Observational 30 participants sought
Prisma Health Cancer Institute — Greenville, South Carolina (7.1 mi)
· Sponsor: University of South Carolina
The Pivotal Study of RapidPulseTM Aspiration System
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
Prisma Health — Greenville, South Carolina (7.1 mi)
· Sponsor: RapidPulse, Inc
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Advanced Solid Tumor, Refractory Hodgkin Lymphoma
Phase 1
Interventional 50 participants sought
Prisma Health-Upstate — Greenville, South Carolina (7.1 mi)
· Sponsor: FBD Biologics Limited
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
Saint Francis Cancer Center - Greenville /ID# 276368 — Greenville, South Carolina (7.1 mi)
· Sponsor: AbbVie
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Spartanburg, South Carolina (24.0 mi)
· Sponsor: AstraZeneca
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
Carolina Nephrology Greenville — Greenville, South Carolina (7.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Prisma Health Cancer Institute - Faris — Greenville, South Carolina (7.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Prisma Health Cancer Institute - Faris — Greenville, South Carolina (7.1 mi)
· Sponsor: NRG Oncology
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
Parkside Pediatrics - Simpsonville- Site Number : 8400005 — Simpsonville, South Carolina (4.2 mi)
· Sponsor: Sanofi
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Steadman Hawkins Clinic of the Carolinas — Greenville, South Carolina (7.1 mi)
· Sponsor: Exactech
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (7.1 mi)
· Sponsor: Children's Oncology Group